Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-02-08 09:25 am Purchase | 2022-12-31 | 13G | Agios Pharmaceuticals, Inc. AGIO | STATE STREET CORP STT | 3,179,068 5.790% | 186,186 (+6.22%) | Filing History |
| 2023-02-06 2:43 pm Purchase | 2022-12-30 | 13G | Agios Pharmaceuticals, Inc. AGIO | WELLINGTON MANAGEMENT CO LLP | 5,462,657 9.940% | 314,091 (+6.10%) | Filing History |
| 2023-01-25 10:36 am Sale | 2022-12-31 | 13G | Agios Pharmaceuticals, Inc. AGIO | BlackRock Inc. BLK | 4,768,874 8.700% | -735,122 (-13.36%) | Filing History |
| 2022-10-06 08:37 am Sale | 2022-09-30 | 13G | Agios Pharmaceuticals, Inc. AGIO | JPMORGAN CHASE & CO JPM | 1,491,001 2.700% | -1,608,568 (-51.90%) | Filing History |
| 2022-09-12 11:13 am Sale | 2022-09-09 | 13G | Agios Pharmaceuticals, Inc. AGIO | FMR LLC | 2,007,111 3.661% | -3,427,202 (-63.07%) | Filing History |
| 2022-03-09 5:18 pm Purchase | 2022-02-28 | 13G | Agios Pharmaceuticals, Inc. AGIO | BlackRock Inc. BLK | 5,503,996 10.100% | 95,460 (+1.76%) | Filing History |
| 2022-02-14 2:34 pm Purchase | 2021-12-31 | 13G | Agios Pharmaceuticals, Inc. AGIO | PRICE T ROWE ASSOCIATES INC | 2,878,714 5.300% | 2,878,714 (New Position) | Filing History |
| 2022-02-11 4:51 pm Purchase | 2021-12-31 | 13G | Agios Pharmaceuticals, Inc. AGIO | BB BIOTECH AG | 4,312,292 7.900% | 153,390 (+3.69%) | Filing History |
| 2022-02-09 4:36 pm Purchase | 2021-12-31 | 13G | Agios Pharmaceuticals, Inc. AGIO | STATE STREET CORP STT | 2,992,882 5.510% | 2,992,882 (New Position) | Filing History |
| 2022-02-09 3:16 pm Sale | 2021-12-31 | 13G | Agios Pharmaceuticals, Inc. AGIO | VANGUARD GROUP INC | 5,068,590 9.330% | -415,984 (-7.58%) | Filing History |
| 2022-02-09 09:09 am Sale | 2022-02-08 | 13G | Agios Pharmaceuticals, Inc. AGIO | FMR LLC | 5,434,313 10.006% | -2,199,667 (-28.81%) | Filing History |
| 2022-02-04 09:12 am Sale | 2021-12-31 | 13G | Agios Pharmaceuticals, Inc. AGIO | WELLINGTON MANAGEMENT CO LLP | 5,148,566 9.480% | -2,728,804 (-34.64%) | Filing History |
| 2022-02-02 7:11 pm Sale | 2021-12-31 | 13G | Agios Pharmaceuticals, Inc. AGIO | BlackRock Inc. BLK | 5,408,536 9.950% | -523,124 (-8.82%) | Filing History |
| 2022-01-19 12:37 pm Purchase | 2021-12-31 | 13G | Agios Pharmaceuticals, Inc. AGIO | JPMORGAN CHASE & CO JPM | 3,099,569 5.700% | 3,099,569 (New Position) | Filing History |
| 2021-12-09 1:54 pm Sale | 2021-11-30 | 13G | Agios Pharmaceuticals, Inc. AGIO | VANGUARD GROUP INC | 5,484,574 10.100% | -141,139 (-2.51%) | Filing History |
| 2021-08-09 3:23 pm Purchase | 2021-07-31 | 13G | Agios Pharmaceuticals, Inc. AGIO | BlackRock Inc. BLK | 5,931,660 10.100% | 1,446,660 (+32.26%) | Filing History |
| 2021-04-05 5:26 pm Unchanged | 2021-04-05 | 13D | Agios Pharmaceuticals, Inc. AGIO | BRISTOL MYERS SQUIBB CO BMY | 0 0.000% | 0 (Unchanged) | Filing History |
| 2021-03-10 09:46 am Purchase | 2021-03-09 | 13G | Agios Pharmaceuticals, Inc. AGIO | FMR LLC | 7,633,980 10.968% | 3,295,314 (+75.95%) | Filing History |
| 2021-02-12 4:11 pm Purchase | 2020-12-31 | 13G | Agios Pharmaceuticals, Inc. AGIO | BB BIOTECH AG | 4,158,902 6.000% | 261,948 (+6.72%) | Filing History |
| 2021-02-10 10:30 am Purchase | 2020-12-31 | 13G | Agios Pharmaceuticals, Inc. AGIO | VANGUARD GROUP INC | 5,625,713 8.120% | 18,858 (+0.34%) | Filing History |